Newsroom

Sorted by: Latest

-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 10.07.2026 UNCU.LN IE00BD6GCF16  880,381.00 USD  42,457,785.07   48.227  ...
-

TIAA-CREF UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Teachers Insurance and Annuity Association of America/TIAA-CREF Investment Management, LLC/Teachers Advisors, LLC/ Nuveen Asset Management, LLC (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The namin...
-

AZN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AstraZeneca (AZN)

NEW YORK--(BUSINESS WIRE)--On July 9, 2026, AstraZeneca (NYSE: AZN) stock fell more than 8% premarket after the Company announced that the Phase III CARDIO-TTransform trial of Wainua missed its primary endpoint in ATTR cardiomyopathy. If you suffered a loss on your AstraZeneca investment, you are encouraged to submit your information here. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. Wainua, a gene-silencing drug for transthyr...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 10.07.2026 FEM IE00B8X9NX34  300,002.00 USD  14,721,276.90   49.071  ...
-

New Research from Cvent Reveals Marketer Confidence in Events as a Pipeline Growth Channel

NASHVILLE, Tenn.--(BUSINESS WIRE)--Cvent opened day one of its flagship Cvent CONNECT conference with an expansive lineup of programming purpose-built for marketing leaders and brand professionals, reflecting a fundamental shift in how leading organizations think about events. A new Cvent study of nearly 1,000 marketers and event professionals puts data behind what many in the industry have long suspected: as AI-generated content proliferates and audience skepticism grows, live events have emer...
-

Massive Bio Announces Partnership with Sequence Me Now to Help Cancer Patients Access Clinical Trials

BOCA RATON, Fla.--(BUSINESS WIRE)--Massive Bio, a technology company that uses artificial intelligence to help cancer patients identify clinical trials for which they may be eligible, today announced a new partnership with Sequence Me Now (SMN), a nonprofit patient advocacy organization dedicated to helping cancer patients access genomic sequencing and personalized medicine. Through the partnership, Massive Bio is featured on the "Find a Trial" page of Sequence Me Now's website, the fourth step...
-

KBRA Releases Research – 21st Century ROAD to Housing Act Becomes Law: SFR Implications

NEW YORK--(BUSINESS WIRE)--KBRA releases research analyzing the 21st Century ROAD to Housing Act, which became federal law on July 11. The act, which is intended to address the nation’s housing shortage and affordability, is expected to have a variety of impacts on the housing sector, including institutional single-family rentals (SFR). Earlier this year, KBRA discussed the potential implications of a prior version of the bill (see Institutional SFR Ownership Limits Could Slow Sector Growth). W...
-

Dayton Rogers Manufacturing to Be Featured on National Television Series World’s Greatest

MINNEAPOLIS--(BUSINESS WIRE)--Dayton Rogers Manufacturing Co., a family-owned leading provider of precision metal forming and short-run metal stamping solutions, will be featured on the nationally televised program World’s Greatest, airing on Bloomberg Television on July 18 and July 25, 2026, at 2:00 PM ET. Founded in 1929, Dayton Rogers has built a reputation for excellence in innovation in short-run sheet metal stamping, custom fabrication, welding, and complete assembly services. Filmed at t...